Japanese CMO Bushu plugs $100M into broad expansion plans for ‘Asia hub’ kblankenship Tue, 08/18/2020 – 14:45 More: Japanese CMO Bushu plugs 0M into broad expansion plans for 'Asia hub' Source: fierce
read moreNovartis and Roche tee up self-injected Xolair option with FDA filing for prefilled syringe fkansteiner Tue, 08/18/2020 – 11:51 More: Novartis and Roche tee up self-injected Xolair option with FDA filing for prefilled syringe Source: fierce
read moreTeva funneled kickbacks through copay assistance charities for MS med Copaxone: DOJ kblankenship Tue, 08/18/2020 – 11:24 More: Teva funneled kickbacks through copay assistance charities for MS med Copaxone: DOJ Source: fierce
read moreAstraZeneca eyes less-frequent Imfinzi dosing with FDA ‘priority’ boost chelfand Tue, 08/18/2020 – 11:21 More: AstraZeneca eyes less-frequent Imfinzi dosing with FDA 'priority' boost Source: fierce
read moreSinopharm chief says COVID-19 vaccine will cost less than $145 for 2-dose regimen aliu Tue, 08/18/2020 – 10:54 More: Sinopharm chief says COVID-19 vaccine will cost less than 5 for 2-dose regimen Source: fierce
read moreEnspryng is the first approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology More: Roche’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals